Negative-strand RNA viral vectors: intravenous application of Sendai virus vectors for the systemic delivery of therapeutic genes (Q42804919)

7 November 2017

title

Negative-strand RNA viral vectors: intravenous application of Sendai virus vectors for the systemic delivery of therapeutic genes (English)

1 reference

7 November 2017

0 references

0 references

Michael Bitzer

1

1 reference

7 November 2017

Guy Ungerechts

2

1 reference

7 November 2017

Sascha Bossow

3

1 reference

7 November 2017

Florian Graepler

4

1 reference

7 November 2017

Reinhard Sedlmeier

5

1 reference

7 November 2017

Sorin Armeanu

6

1 reference

7 November 2017

Christian Bernloehr

7

1 reference

7 November 2017

Martin Spiegel

8

1 reference

7 November 2017

Christine D Gross

9

1 reference

7 November 2017

Michael Gregor

10

1 reference

7 November 2017

Wolfgang J Neubert

11

1 reference

7 November 2017

Ulrich M Lauer

12

1 reference

7 November 2017

publication date

1 February 2003

1 reference

7 November 2017

1 reference

7 November 2017

volume

7

1 reference

7 November 2017

issue

2

1 reference

7 November 2017

page(s)

210-217

1 reference

Gene transfer for cystic fibrosis

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Gene therapy for metabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Gene therapy for the hemophilias

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Gene therapy: trials and tribulations

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Nonsegmented negative-strand RNA viruses: genetics and manipulation of viral genomes

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Negative-strand RNA viruses: genetic engineering and applications

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Efficient gene transfer to airway epithelium using recombinant Sendai virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

The replicative complex of paramyxoviruses: structure and function.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

A CXCR4/CD4 Pseudotype Rhabdovirus That Selectively Infects HIV-1 Envelope Protein-Expressing Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

The nasal epithelium as a factory for systemic protein delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Feeding suppression by fibroblast growth factor-1 is accompanied by selective induction of heat shock protein 27 in hypothalamic astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Sustained correction of bleeding disorder in hemophilia B mice by gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Apoptosis signaling by death receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Tumor angiogenesis--new drugs on the block

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Budding site of sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Parainfluenza (Sendai) virus infects ciliated cells and secretory cells but not basal cells of rat tracheal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Virus activation by host proteinases. A pivotal role in the spread of infection, tissue tropism and pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Successful expression of human factor IX following repeat administration of adenoviral vector in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

1 reference

7 January 2021

Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32).

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

The short Sendai virus leader region controls induction of programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Comparison of protective effects of serum antibody on respiratory and systemic infection of Sendai virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and In vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

Sendai virus efficiently infects cells via the asialoglycoprotein receptor and requires the presence of cleaved F0 precursor proteins for this alternative route of cell entry

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900052-7

7 January 2021

10.1016/S1525-0016(02)00052-7

Identifiers

DOI

1 reference

7 November 2017

1 reference